Molecular imaging is the visualization, characterization, and measurement of biologic
processes at the molecular and cellular levels in humans and other living systems …

Functional brain imaging in depressive disorder aims to map brain areas associated with
depressive illness or to define the neurochemical correlates of the illness and its treatment …

The recent increase in radioligands available for neuroimaging major depressive disorder
has led to advancements in our understanding of the pathophysiology of this illness and …

Mood disorders are chronic, recurrent psychiatric disorders with high morbidity rates that
cause severe disability. Researchers have used molecular imaging extensively in studies of …

Molecular imaging with PET or SPECT has been an important research tool in psychiatry for
as long as these modalities have been available. Here, we discuss two areas of …

Neuroanatomical and physiological imaging provide unprecedented opportunities to
examine the biological substrates of major mental disorders such as late life major …

The role of in vivo neurotransmitter system imaging studies in understanding major depression. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

The in vivo study of receptor binding potential in the human brain is made possible by
positron emission tomography (PET) imaging. Here we review PET studies of neuroreceptor …

Single photon emission computed tomography (SPECT) and positron emission tomography
(PET) have advanced our understanding of the biological underpinnings of depression …

Converging clinical, biochemical, postmortem, and neuroimaging evidence suggests that
depression is unlikely to be a disease of a single brain region or neurotransmitter system …